Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of switching efavirenz to rilpivirine in HIV-infected patients with dyslipidemia
TCTR20141019001Phase 4Recruiting
- Sponsor
- Infectious Diseases Association of Thailand
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rilpivirine in human immunodeficiency virus infection (HIV), dyslipidemia, sponsored by Infectious Diseases Association of Thailand. Started Jun 2014; status: recruiting.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)dyslipidemia
Beyond the preview
Go deeper on TCTR20141019001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20141019001.